27 Mar 2024


26 March 2024: Trilegal represented MEMG Family Office LLP (MEMG LLP) and 360 One Private Equity Fund (360 One) in securing an unconditional approval from the Competition Commission of India (CCI) in relation to the proposed subscription of compulsorily convertible preference shares in API Holdings Limited (API). The CCI approved the transaction on 26 March 2024.
Trilegal represented MEMG LLP and 360 One on the Indian competition law aspects of the transaction and filed a merger notification with the CCI. Trilegal demonstrated that the proposed transaction would not cause any appreciable adverse effect on competition in any of the relevant markets in India.
MEMG LLP, incorporated in India, is part of the Manipal Education and Medical Group. 360 One is a Securities and Exchange Board of India (SEBI) registered fund, established for undertaking investment activities in India and abroad. API is engaged in various activities in the pharmaceutical and healthcare sector in India and owns the ‘Pharmeasy’ platform.
Trilegal competition team was led by Nisha Kaur Uberoi, Partner & National Head – Competition Law and Rudresh Singh, Partner; and assisted by Anand Sree, Senior Associate; Kamal Sharma, Senior Associate; Vasudha Verma, Shaurya Kashyap and Mehar Singh Dang, Associates.
For more information, please contact:
Roomi Irani
Mob: +91-2240791000 | BD@trilegal.com

Deal: Trilegal advises Macquarie Corporate Holdings on the sale of Vibrant Energy to Inox Clean Energy

Deal: Trilegal advises Elliott Investment Management L.P. on CCI approval for its significant investment in Toyota Industries Corporation

The quiet death of ADRs: Why investors no longer need Wall Street’s window into India
Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website, www.trilegal.com, you acknowledge that:
We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:
For more information, please read our terms of use and our privacy policy.